These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 28674314)
1. Time-Lapse Tracking of Candida tropicalis Biofilm Formation and the Antifungal Efficacy of Liposomal Amphotericin B. Kawai A; Yamagishi Y; Mikamo H Jpn J Infect Dis; 2017 Sep; 70(5):559-564. PubMed ID: 28674314 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms. Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J J Antimicrob Chemother; 2016 Sep; 71(9):2498-501. PubMed ID: 27147303 [TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms. Kawai A; Yamagishi Y; Mikamo H J Infect Chemother; 2015 Sep; 21(9):647-53. PubMed ID: 26141813 [TBL] [Abstract][Full Text] [Related]
4. Candida tropicalis biofilm's matrix--involvement on its resistance to amphotericin B. Fernandes T; Silva S; Henriques M Diagn Microbiol Infect Dis; 2015 Oct; 83(2):165-9. PubMed ID: 26189843 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection. Fujimoto K; Takemoto K J Infect Chemother; 2018 Dec; 24(12):958-964. PubMed ID: 30209024 [TBL] [Abstract][Full Text] [Related]
6. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. Jafri H; Ahmad I J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964 [TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms]. Valentín A; Cantón E; Pemán J; Quindós G Rev Iberoam Micol; 2007 Dec; 24(4):272-7. PubMed ID: 18095759 [TBL] [Abstract][Full Text] [Related]
8. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. Al-Fattani MA; Douglas LJ J Med Microbiol; 2006 Aug; 55(Pt 8):999-1008. PubMed ID: 16849719 [TBL] [Abstract][Full Text] [Related]
9. Effect of antifungal agents, lysozyme and human antimicrobial peptide LL-37 on clinical Chen YC; Chen FJ; Lee CH J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33252326 [No Abstract] [Full Text] [Related]
10. Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals. Vipulanandan G; Herrera M; Wiederhold NP; Li X; Mintz J; Wickes BL; Kadosh D J Dent Res; 2018 Jan; 97(1):91-98. PubMed ID: 28850289 [TBL] [Abstract][Full Text] [Related]
11. Candida tropicalis from veterinary and human sources shows similar in vitro hemolytic activity, antifungal biofilm susceptibility and pathogenesis against Caenorhabditis elegans. Brilhante RSN; Oliveira JS; Evangelista AJJ; Serpa R; Silva ALD; Aguiar FRM; Pereira VS; Castelo-Branco DSCM; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Rocha MFG Vet Microbiol; 2016 Aug; 192():213-219. PubMed ID: 27527785 [TBL] [Abstract][Full Text] [Related]
12. The anthraquinones rubiadin and its 1-methyl ether isolated from Heterophyllaea pustulata reduces Candida tropicalis biofilms formation. Marioni J; da Silva MA; Cabrera JL; Montoya SC; Paraje MG Phytomedicine; 2016 Nov; 23(12):1321-1328. PubMed ID: 27765351 [TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of amphotericin B and tyrosol on biofilm formed by Candida krusei and Candida tropicalis from intrauterine device users. Shanmughapriya S; Sornakumari H; Lency A; Kavitha S; Natarajaseenivasan K Med Mycol; 2014 Nov; 52(8):853-61. PubMed ID: 25202127 [TBL] [Abstract][Full Text] [Related]
14. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production. de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of biofilm formation by Candida tropicalis and antifungal resistance. Bizerra FC; Nakamura CV; de Poersch C; Estivalet Svidzinski TI; Borsato Quesada RM; Goldenberg S; Krieger MA; Yamada-Ogatta SF FEMS Yeast Res; 2008 May; 8(3):442-50. PubMed ID: 18248413 [TBL] [Abstract][Full Text] [Related]
16. Role of Non Albicans Candida Spp. and Biofilm in Neonatal ICU. Goel S; Mittal S; Chaudhary U Infect Disord Drug Targets; 2016; 16(3):192-198. PubMed ID: 27538491 [TBL] [Abstract][Full Text] [Related]
17. Lack of efficacy of echinocandins against high metabolic activity biofilms of Candida parapsilosis clinical isolates. Thomaz DY; Melhem MSC; de Almeida Júnior JN; Benard G; Del Negro GMB Braz J Microbiol; 2020 Sep; 51(3):1129-1133. PubMed ID: 31898245 [TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model. El-Azizi M; Farag N; Khardori N Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806 [TBL] [Abstract][Full Text] [Related]
19. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Negri M; Martins M; Henriques M; Svidzinski TI; Azeredo J; Oliveira R Mycopathologia; 2010 Mar; 169(3):175-82. PubMed ID: 19851885 [TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility testing of Candida tropicalis biofilms against fluconazole using calorimetric indicator resazurin. Punithavathy PM; Nalina K; Menon T Indian J Pathol Microbiol; 2012; 55(1):72-4. PubMed ID: 22499305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]